TSLP and dermatitis: Altogether, these data indicate that IFN-γ-iMSC-EVs ameliorate skin inflammation by inhibiting the proliferation of immune cells and blocking TSLP expression, all of which might be involved in the reduced activity of the NF-κB pathway.